|
March 21, 2022
|
Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
|
|
|
March 8, 2022
|
Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
|
|
|
March 7, 2022
|
Caribou Biosciences to Present at Upcoming Investor Conferences
|
|
|
February 7, 2022
|
Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference
|
|
|
January 18, 2022
|
Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer
|
|
|
January 4, 2022
|
Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
|
|
